Didier Meulendijks

Safety, tolerability, pharmacokinetics, and antitumor activity of adavosertib in Japanese patients with advanced solid tumors: A phase I, open-label study.

M. Sugeno, T. Kawata, Shunsuke Kondo, 2024, Cancer treatment and research communications.